Digital health companies' plans focused on managing the impact of GLP-1 drugs, which have placed enormous pressure on health ...

Weight management platform Found is today launching oral semaglutide dissolvable tablets for individuals looking for alternative ways to administer anti-obesity drugs. | Found is offering a cheaper, ...

Just when you thought there couldn’t be investor appetite for yet another GLP-1-focused obesity biotech, Verdiva Bio has ...

Oral pills like HS-10535, if approved as weight loss drugs ... GLP-1 receptor, from a Chinese biotech in November 2023. Merck has a Zacks Rank #3 (Hold) at present. You can see the complete list ...

Hello, Health Rounds Readers! Today we feature a study that found yet another potential health benefit of GLP-1 drugs, this ...

Each brand has its own formula for helping users achieve their weight loss goals. Their methods include remote healthcare ...

Metsera (MTSR), which is developing ultra-long-acting drugs for the treatment of obesity, has filed for a $100M initial ...

From loss of skin elasticity to hair density, supplements that offer targeted support for GLP-1 users, as well as those that ...

It's possible that Alzheimer's disease could be added to the lengthening list of ... injectable GLP-1 agonist liraglutide in people with early-stage Alzheimer's has shown that the drug was able ...

As weight loss medications such as Ozempic ... a warning letter to Veronvy for offering unapproved and misbranded oral GLP-1 products, including one claiming to be FDA certified.

Glucagon-like peptide-1 (GLP-1) medications are doing more than transforming waistlines and blood sugar levels — they're redefining corporate culture. As employers grapple with including GLP-1s in ...

To foray into the lucrative obesity market, Merck MRK announced that it is in-licensing global rights to an investigational oral ... The GLP-1 segment is a very important class of drugs for ...